Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - NUTRA PHARMA CORP | v355789_ex99-1.htm |
| EX-99.2 - EXHIBIT 99.2 - NUTRA PHARMA CORP | v355789_ex99-2.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 25, 2013
NUTRA PHARMA CORP.
(Exact name of registrant as specified in its charter)
| California | 000-32141 | 91-2021600 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 12502 West Atlantic Blvd, Coral Springs, Florida | 33071 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (954) 509-0911
Registrant’s facsimile number, including area code: (877) 895-5647
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 Other Events
Item 8.01 Issuance of Press Release and Shareholder Letter
On September 25, 2013, we issued a press release announcing the publication of an open Letter to Shareholders from the Company's CEO, Rik J Deitsch.
A copy of the press release is attached as Exhibit 99.1 and incorporated herein by reference.
A copy of the Letter to Shareholders is attached as Exhibit 99.2 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
| Exhibit No. | Exhibit Description | |
|
99.1 99.2 |
Press release posted on September 25, 2013. Letter to Shareholders published to the Company's website on September 25, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: September 25, 2013 | NUTRA PHARMA CORP. | ||
| By: | /s/ Rik J Deitsch | ||
| Name: | Rik J Deitsch | ||
| Title: | Chief Executive Officer/ Director | ||